Insider Transactions in Q1 2024 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
3,760
-1.94%
|
$41,360
$11.12 P/Share
|
|
Mar 04
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
14,903
-1.68%
|
$163,933
$11.12 P/Share
|
|
Mar 04
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
4,782
-1.74%
|
$52,602
$11.12 P/Share
|
|
Mar 04
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,468
-2.32%
|
$38,148
$11.12 P/Share
|
|
Mar 04
2024
|
Patrick J Heron Director |
BUY
Open market or private purchase
|
Indirect |
21,052
+0.24%
|
$189,468
$9.5 P/Share
|
|
Feb 28
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,465
-0.28%
|
$24,650
$10.6 P/Share
|
|
Feb 13
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94,898
+14.3%
|
-
|
|
Feb 13
2024
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
189,050
+14.91%
|
-
|
|
Feb 13
2024
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
264,882
+7.55%
|
-
|
|
Feb 13
2024
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
119,550
+18.47%
|
-
|
|
Feb 13
2024
|
John W Smither Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,365
+46.5%
|
-
|
|
Jan 12
2024
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+24.77%
|
-
|
|
Jan 12
2024
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+16.62%
|
-
|
|
Jan 12
2024
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+27.28%
|
-
|
|
Jan 12
2024
|
Larry Todd Edwards SVP Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+24.14%
|
-
|
|
Jan 12
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+33.9%
|
-
|
|
Jan 02
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
1,325
-2.27%
|
$3,975
$3.54 P/Share
|